New York, NEW%20YORK6 Active Studies

Sarcoma Soft Tissue Clinical Trials in New York, NEW%20YORK

Find 6 actively recruiting sarcoma soft tissue clinical trials in New York, NEW%20YORK. Connect with local research sites and explore new treatment options.

6
Active Trials
5
Sponsors
1,299
Enrolling

Recruiting Sarcoma Soft Tissue Studies in New York

RecruitingNew York, NEW%20YORKNCT06876649

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

The master protocol study J2N-MC-JZNY provides a framework to enable the evaluation of the long-term safety and efficacy of pirtobrutinib after completion of clinical studies evaluating pirtobrutinib....

787 participants
Eli Lilly and Company
View Study Details
RecruitingNew York, NEW%20YORKNCT06797999

First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma

The goal of this clinical trial is to learn about the safety, tolerability and efficacy of ADCE-D01....

270 participants
Adcendo ApS
View Study Details
RecruitingNew York, NEW%20YORKNCT05551793

Regeneron AA Multicenter (Dupilumab)

This is a prospective, randomized, double blind, placebo-controlled clinical trial. The study will take place at 4 sites. This trial will enroll a total of 68 patients with moderate to severe AA (affe...

68 participants
Emma Guttman
View Study Details
RecruitingNew York, NEW%20YORKNCT04288375

Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs

The investigators are doing this study to find out whether lowering the dose of postoperative radiation therapy and targeting a smaller area of tissue for treatment is as effective as the standard dos...

60 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingNew York, NEW%20YORKNCT05004987

Aβ Dynamics in LLMD

This study will examine the biological factors that may modulate the relationship between depression and the development of Alzheimer's disease (AD). Since the direction of causation between depressio...

60 participants
NYU Langone Health
View Study Details
RecruitingNew York, NEW%20YORKNCT06843967

A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

The purpose of this study is to find out whether mirdametinib in combination with palbociclib is an effective and safe treatment for people with metastatic, recurrent, and unresectable liposarcoma. Th...

54 participants
Memorial Sloan Kettering Cancer Center
View Study Details

About Sarcoma Soft Tissue Clinical Trials in New York

Soft tissue sarcomas are rare cancers that develop in the soft tissues of the body including muscle, fat, blood vessels, and tendons. There are more than 50 subtypes, each with different characteristics. Treatment includes surgery, radiation, and chemotherapy, with newer targeted therapies under investigation.

There are currently 6 sarcoma soft tissue clinical trials recruiting participants in New York, NEW%20YORK. These studies are seeking a combined 1,299 participants. Research is being sponsored by Eli Lilly and Company, Adcendo ApS, Emma Guttman and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Sarcoma Soft Tissue Clinical Trials in New York — FAQ

Are there sarcoma soft tissue clinical trials in New York?

Yes, there are 6 sarcoma soft tissue clinical trials currently recruiting in New York, NEW%20YORK. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New York?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.

Are clinical trials in New York free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.

What sarcoma soft tissue treatments are being tested?

The 6 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for sarcoma soft tissue.

Data updated March 2, 2026 from ClinicalTrials.gov